Bessemer Group’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $279K | Buy |
14,964
+135
| +0.9% | +$2.52K | ﹤0.01% | 1015 |
|
|
2025
Q1 | $269K | Hold |
14,829
| – | – | ﹤0.01% | 1025 |
|
|
2024
Q4 | $323K | Hold |
14,829
| – | – | ﹤0.01% | 988 |
|
|
2024
Q3 | $406K | Hold |
14,829
| – | – | ﹤0.01% | 951 |
|
|
2024
Q2 | $384K | Hold |
14,829
| – | – | ﹤0.01% | 871 |
|
|
2024
Q1 | $445K | Hold |
14,829
| – | – | ﹤0.01% | 839 |
|
|
2023
Q4 | $154K | Hold |
14,829
| – | – | ﹤0.01% | 1098 |
|
|
2023
Q3 | $203K | Sell |
14,829
-2
| -0% | -$27 | ﹤0.01% | 1028 |
|
|
2023
Q2 | $180K | Hold |
14,831
| – | – | ﹤0.01% | 1077 |
|
|
2023
Q1 | $189K | Hold |
14,831
| – | – | ﹤0.01% | 910 |
|
|
2022
Q4 | $94K | Buy |
14,831
+1
| +0% | +$6 | ﹤0.01% | 1051 |
|
|
2022
Q3 | $335K | Hold |
14,830
| – | – | ﹤0.01% | 810 |
|
|
2022
Q2 | $285K | Hold |
14,830
| – | – | ﹤0.01% | 816 |
|
|
2022
Q1 | $688K | Hold |
14,830
| – | – | ﹤0.01% | 558 |
|
|
2021
Q4 | $1.05M | Hold |
14,830
| – | – | ﹤0.01% | 450 |
|
|
2021
Q3 | $1.73M | Hold |
14,830
| – | – | ﹤0.01% | 334 |
|
|
2021
Q2 | $2.32M | Hold |
14,830
| – | – | 0.01% | 304 |
|
|
2021
Q1 | $2.81M | Hold |
14,830
| – | – | 0.01% | 290 |
|
|
2020
Q4 | $1.86M | Hold |
14,830
| – | – | ﹤0.01% | 311 |
|
|
2020
Q3 | $1.61M | Hold |
14,830
| – | – | ﹤0.01% | 347 |
|
|
2020
Q2 | $1.78M | Hold |
14,830
| – | – | 0.01% | 521 |
|
|
2020
Q1 | $1.49M | Hold |
14,830
| – | – | 0.01% | 504 |
|
|
2019
Q4 | $3.6M | Hold |
14,830
| – | – | 0.01% | 409 |
|
|
2019
Q3 | $2.43M | Hold |
14,830
| – | – | 0.01% | 465 |
|
|
2019
Q2 | $3.5M | Hold |
14,830
| – | – | 0.01% | 391 |
|
|
2019
Q1 | $3.91M | Hold |
14,830
| – | – | 0.02% | 317 |
|
|
2018
Q4 | $1.35M | Buy |
+14,830
| New | +$1.35M | 0.01% | 500 |
|